Search Articles

REFINE SEARCH
1287 Results   |   Clear Filters

Medical Service

Person

Tag

Search results

Displaying 1261 - 1280 of 1287

Cancer survivors stand strong together
Cancer,
Community,
News about UCLA Health

Grant from Avon Foundation to fund program to help poor, underserved patients

A $1.16 million grant from the Avon Foundation will fund a program that helps poor, underserved patients being treated for breast cancer at Olive View-UCLA Medical Center navigate their way through the complicated county health care system.
September 19, 2007   |  
4 min read
Isla P. Garraway, MD, PhD
Cancer,
Science & Research

Prostate Cancer Took Her Father's Life, Now Daughter Seeks New Therapies

Isla Garraway was a researcher working toward her doctorate degree in a lab at UCLA’s Jonsson Comprehensive Cancer Center when her father was diagnosed with prostate cancer in 1994. He was just 61.
June 15, 2007   |  
3 min read
Cancer,
Community,
Healthy Lifestyle

Exhibit Features Works Created by Cancer Patients and Survivors in Art Therapy Group

The irony isn't lost on Woodland Hills resident Karen Kaufman. It was two bouts with two different cancers in less than a year that helped her return to her first true passion - art.
May 2, 2007   |  
5 min read
Dr. Antoni Ribas UCLA
Cancer,
News about UCLA Health,
Science & Research

Jonsson Cancer Center Receives $1 Million Gift to Establish Melanoma Fellowship

UCLA’s Jonsson Comprehensive Cancer Center has received a $1 million gift to establish The V Foundation-Gil Nickel Fellowship in Melanoma Research. The fellowship will train a new generation of promising young scientists who will go on to conduct leading-edge melanoma research at UCLA and other top institutions nationwide.
April 25, 2007   |  
3 min read
Cancer,
Science & Research

Common Prostate Cancer Treatments Impact on a Patient's Quality of Life

A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways. The findings provide invaluable information for men with prostate cancer who are facing vital treatment decisions.
April 23, 2007   |  
5 min read
Cancer cells
Cancer,
Science & Research

UCLA Researchers Discover Novel Signaling Pathway That May Help Maintain Immune System Balance

Researchers at UCLA's Jonsson Cancer Center have discovered a novel anti-inflammatory cell signaling pathway that may serve as a vital Yin-Yang mechanism to maintain the delicate balance of immune response.
April 1, 2007   |  
2 min read
UCLA Health article
Science & Research

Few Primary Care Practitioners Offer HIV Tests to Hispanic Patients in Los Angeles, New UCLA AIDS Institute Study Finds

Even as the AIDS epidemic in Los Angeles County has shifted largely to Hispanics, primary care practitioners serving this segment of the population often fail to offer either HIV testing or safer sex advice to their patients, according to a new UCLA AIDS Institute study.
March 1, 2007   |  
4 min read
Cluster of cancer cells
Cancer,
News about UCLA Health,
Science & Research

California Awards First Stem Cell Research Grants; UCLA Scientists Garner 7 of 72 Grants Given

UCLA scientists have received seven of 72 seed grants awarded by the state to fund stem cell research, the first money distributed for work on human embryonic stem cells since California voters approved Proposition 71 in November 2004. Seed grant funding totaled $45 million.
February 20, 2007   |  
4 min read
Dr. Dennis Slamon
Cancer,
Science & Research

Survival Increased in Early Stage Breast Cancer After Herceptin-Chemotherapy Treatment

Combining the molecularly targeted therapy Herceptin with chemotherapy in women with early stage breast cancer significantly improves disease-free survival for patients with a specific genetic mutation that results in very aggressive disease, a top UCLA researcher reported Thursday.
December 15, 2006   |  
4 min read
Blue ribbon colorectal cancer awareness
Science & Research

UCLA Researchers Develop Quality Measures for Colorectal Cancer Surgery Patients

A set of quality measures used to evaluate the quality of care received by patients undergoing surgery for colorectal cancer has been created by UCLA researchers in an effort to improve care before, during and after the surgery.
November 29, 2006   |  
4 min read
Image
Cancer,
Science & Research

Researchers Seek Current and Ex-Smokers for Novel Lung Cancer Prevention Studies

Researchers at UCLA's Jonsson Cancer Center are seeking volunteers for two studies testing drugs used to treat other diseases to determine if they're effective in preventing lung cancer, the leading cause of cancer death in men and women.
November 3, 2006   |  
2 min read
Doctor examines a patient for potential melanoma
Cancer,
Science & Research

Melanomas Cripple Lymph Node Immune Function so They Can Spread to Other Parts of the Body

Melanomas aid themselves in their quest to spread to other parts of the body by sending a chemical signal to the sentinel lymph node, the node most susceptible to early spread of the cancer. The signal cripples the sentinel node's immune response, making it more vulnerable to the cancer, UCLA researchers discovered.
October 12, 2006   |  
4 min read
Allan Pantuck
Cancer,
Healthy Lifestyle,
Science & Research

Pomegranate Juice Keeps PSA Levels Stable in Men Treated for Prostate Cancer

Drinking an eight ounce glass of pomegranate juice daily increased by nearly four times the period during which PSA levels in men treated for prostate cancer remained stable, a three-year UCLA study has found.
July 1, 2006   |  
4 min read
Steven M. Dubinett, MD
Cancer,
Science & Research

Experimental Therapy Shows Promise in Patients with Advanced Lung Cancer

An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported.
June 1, 2006   |  
4 min read
Cancer,
Healthy Lifestyle,
Science & Research

Breast Cancer Survivors with Fatigue have Immune Systems that Fail to Shut Down

Breast cancer survivors who suffer from persistent, debilitating fatigue years after their diagnosis have something in common: their immune systems don’t shut down following treatment, according to researchers at UCLA’s Jonsson Cancer Center.
May 1, 2006   |  
5 min read
Dr. Owen N. Witte
Cancer,
Science & Research
A close-up of nanoparticles.
Cancer,
News about UCLA Health,
Science & Research

Cancer Center Scientists Team with Other Researchers on Nanotechnology Project

Investigators from UCLA's Jonsson Cancer Center are teaming up with researchers from the California Institute of Technology, the UCLA Institute for Molecular Medicine (IMED) and the Institute for Systems Biology (ISB) in Seattle to develop new technologies for early detection and classification of cancers.
October 12, 2005   |  
3 min read
Dr. Patricia Ganz
Cancer,
Science & Research

Intervention Program Failed to Increase Colorectal Cancer Screening Rates

An intervention program designed to promote screening for colorectal cancer - and thereby decrease the number of cancers diagnosed - failed to increase screening rates in the managed care setting, a UCLA study has found.
October 10, 2005   |  
3 min read
Harvey Herschman
Cancer,
News about UCLA Health,
Science & Research

NCI Renews $10 Million Grant for Molecular Imaging Center for Cancer Research

The National Cancer Institute (NCI) has renewed, for a second five-year period, a $10-million grant for an innovative molecular imaging center at UCLA, officials announced today. The new funding, bringing UCLA's total support to $20 million, will allow the scientific advances made in the last five years to be translated into the clinic in the next five years to improve the diagnosis and staging of cancer.
July 27, 2005   |  
4 min read
Steven M. Dubinett, MD
Cancer,
Science & Research

Researchers Discover Possible Target for Celebrex Therapy in Lung Cancer

A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.
July 15, 2005   |  
3 min read